Manulife (Manufacturers Life Insurance)
RLAY icon

Manulife (Manufacturers Life Insurance)’s Relay Therapeutics RLAY Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93M Buy
263,506
+53,799
+26% +$781K ﹤0.01% 1198
2026
Q1 		$2.09M Buy
209,707
+32,221
+18% +$288K ﹤0.01% 1480
2025
Q4 		$1.49M Buy
177,486
+15,021
+9% +$107K ﹤0.01% 1661
2025
Q3 		$848K Sell
162,465
-49,661
-23% -$189K ﹤0.01% 1944
2025
Q2 		$734K Buy
212,126
+6,547
+3% +$19.5K ﹤0.01% 1966
2025
Q1 		$539K Sell
205,579
-13,293
-6% -$52.1K ﹤0.01% 2108
2024
Q4 		$902K Buy
218,872
+3,325
+2% +$18.1K ﹤0.01% 1955
2024
Q3 		$1.53M Sell
215,547
-41
-0% -$306 ﹤0.01% 1693
2024
Q2 		$1.41M Sell
215,588
-19,598
-8% -$134K ﹤0.01% 1660
2024
Q1 		$1.95M Sell
235,186
-3,870
-2% -$37.8K ﹤0.01% 1525
2023
Q4 		$2.63M Sell
239,056
-1,040
-0.4% -$8.78K ﹤0.01% 1384
2023
Q3 		$2.02M Buy
240,096
+34,535
+17% +$371K ﹤0.01% 1433
2023
Q2 		$2.58M Buy
205,561
+37,406
+22% +$465K ﹤0.01% 1331
2023
Q1 		$2.77M Buy
168,155
+61,822
+58% +$1.11M ﹤0.01% 1302
2022
Q4 		$1.58M Buy
106,333
+3,188
+3% +$61K ﹤0.01% 1451
2022
Q3 		$2.36M Buy
103,145
+6,977
+7% +$153K ﹤0.01% 1342
2022
Q2 		$1.61M Buy
96,168
+7,606
+9% +$163K ﹤0.01% 1474
2022
Q1 		$2.69M Buy
88,562
+53,376
+152% +$1.3M ﹤0.01% 1431
2021
Q4 		$1.1M Buy
35,186
+3,992
+13% +$126K ﹤0.01% 1770
2021
Q3 		$984K Sell
31,194
-1,955
-6% -$65.8K ﹤0.01% 1854
2021
Q2 		$1.21M Buy
33,149
+7,020
+27% +$231K ﹤0.01% 1877
2021
Q1 		$903K Buy
26,129
+6,345
+32% +$275K ﹤0.01% 1952
2020
Q4 		$822K Buy
19,784
+2,187
+12% +$98.9K ﹤0.01% 1936
2020
Q3 		$749K Buy
+17,597
New +$671K ﹤0.01% 1794

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RLAY Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Relay Therapeutics (RLAY) stake by 26% in Q2 2026, buying an estimated $781K and bringing the position to 263,506 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Manulife (Manufacturers Life Insurance) first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 263,506 shares of Relay Therapeutics worth $4.93M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 53,799 Relay Therapeutics shares in Q2 2026, an estimated $781K.
  • Relay Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1198 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.